Laser Therapy Versus Narrow Band Ultraviolet B for the Treatment of Acne Vulgaris

• Status: Completed
• Trial end date: 2019-06-30
• Target enrollment: 0
• Participant gender: All

Summary

Forty-five participants with facial AV were assigned randomly to three groups of fifteen subjects each. Each group received various therapies. Group A (Study group A) had received both NBUB and akne-Mycin; Group B( study group B) had received Red LLLT and akne-Mycin and group C (Control group) received only akne-Mycin cream. All 45 participants are tested at the initial treatments, after 4 weeks and after 8 weeks by the acne count, the intensity scale and the photographic test.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Erythromycin stearate

Criteria

Inclusion Criteria:

• Ages ranged from 18-35 years.

• Skin type III and IV.

• Mild to moderate facial acne.

Exclusion Criteria:

• Treatment with oral retinoid within past 1 year.

• Treatment with other acne treatment within past 3 months.

• History of treatment with systemic and topical antibiotics for acne vulgaris within the last 1 month.

• Treatment with oral isotretinoin within the last 6 months.

• Participants received radiotherapy or chemotherapy.

• Any history of photosensitivity.

• Chemical peels during the previous 4 weeks.

• Seizures,

• Pregnancy

• Use of oral contraceptives.

• Breastfeeding .